Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group. - Vikelis, Michail; Rikos, Dimitrios; Argyriou, Andreas A.; Soldatos, Panagiotis; Tsironis, Christos; Giakoumakis, Emmanouil; Xiromerisiou, Georgia; Chondrogianni, Maria; Foska, Aikaterini; Koutsokera, Maria; Notas, Konstantinos; Mavraki, Eleni; et al. (Neurology International, 2026)